Stomacare 900 mg Tablet is a Health Canada–registered human drug (DIN 00854751) held by Nu-Life Nutrition Ltd., containing Glycyrrhiza Glabra. Health Canada lists its status as Cancelled Post Market (status date 03 Mar 2000). Nexara Health has matched 10 registrations of Glycyrrhiza Glabra across 2 other regulated markets.
Health Canada registration
| DIN | 00854751 |
|---|---|
| Brand name | Stomacare |
| Active ingredient | Glycyrrhiza Glabra |
| Strength | 900 mg |
| Dosage form | Tablet |
| Route | Oral |
| Company | Nu-Life Nutrition Ltd. |
| Status | Cancelled Post Market — 03 Mar 2000 |
| Class | Human |
| ATC | |
| AHFS | 92:01.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Glycyrrhiza Glabra registered in other markets
10 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Malaysia | Himalaya Digestive Wellness Capsules | Himalaya Wellness Malaysia Sdn. Bhd. | Natural Product | PRODUCT APPROVED | NPRA | |
| Malaysia | Kordel's Estomac Vegetable Capsule | Mb Nutraceuticals Sdn Bhd | Natural Product | PRODUCT APPROVED | NPRA | |
| United States | Glycyrrhiza Glabra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Glycyrrhiza Glabra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Glycyrrhiza Glabra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Glycyrrhiza Glabra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Glycyrrhiza Glabra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Glycyrrhiza Glabra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Glycyrrhiza Glabra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Glycyrrhiza Glabra | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Glycyrrhiza Glabra worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Stomacare (DIN 00854751) marketed in Canada?
No. Health Canada lists DIN 00854751 as Cancelled Post Market as of 03 Mar 2000.
Who holds the Canadian licence for this product?
Nu-Life Nutrition Ltd. is the company of record in the Health Canada Drug Product Database.
Is Glycyrrhiza Glabra registered outside Canada?
Yes — Nexara Health has matched 10 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00854751, status date 2000-03-03; national medicine registries: FDA NDC, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00854751, status date 2000-03-03; national medicine registries: FDA NDC, NPRA.
Health Canada Drug Product Database (DPD), DIN 00854751, status date 2000-03-03; national medicine registries: FDA NDC, NPRA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.